Singapore markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
319.98-1.47 (-0.46%)
At close: 04:00PM EST
318.80 -1.18 (-0.37%)
Pre-market: 04:30AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 82.51B
Enterprise value 73.57B
Trailing P/E 25.39
Forward P/E 20.08
PEG Ratio (5 yr expected) 0.42
Price/sales (ttm)9.54
Price/book (mrq)6.33
Enterprise value/revenue 8.46
Enterprise value/EBITDA 17.40

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 330.85%
S&P500 52-week change 3-11.63%
52-week high 3324.75
52-week low 3225.28
50-day moving average 3305.29
200-day moving average 3288.65

Share statistics

Avg vol (3-month) 31.41M
Avg vol (10-day) 31.55M
Shares outstanding 5256.69M
Implied shares outstanding 6N/A
Float 8256.06M
% held by insiders 10.19%
% held by institutions 197.09%
Shares short (12 Jan 2023) 42.63M
Short ratio (12 Jan 2023) 42
Short % of float (12 Jan 2023) 41.03%
Short % of shares outstanding (12 Jan 2023) 41.03%
Shares short (prior month 14 Dec 2022) 43.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 37.62%
Operating margin (ttm)36.89%

Management effectiveness

Return on assets (ttm)13.68%
Return on equity (ttm)29.02%

Income statement

Revenue (ttm)8.7B
Revenue per share (ttm)34.05
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)3.62B
EBITDA 3.35B
Net income avi to common (ttm)3.27B
Diluted EPS (ttm)12.68
Quarterly earnings growth (yoy)9.20%

Balance sheet

Total cash (mrq)9.77B
Total cash per share (mrq)38.06
Total debt (mrq)824.6M
Total debt/equity (mrq)6.33
Current ratio (mrq)4.70
Book value per share (mrq)50.77

Cash flow statement

Operating cash flow (ttm)4.05B
Levered free cash flow (ttm)2.47B